Anastrozole
Presentación: 60tb
Referencia del proveedor: Anastro-Med
Product Description Anastro-med by Bioniche Pharma is a pharmaceutical-grade aromatase inhibitor (AI) containing 1 mg of Anastrozole per tablet. Designed to block the aromatase enzyme, it effectively prevents the conversion of androgens into estrogens, reducing serum estradiol levels by up to 80% or more. In medical settings, it manages breast cancer, while bodybuilders employ it during anabolic cycles to control estrogenic side effects.
Bodybuilding Administration Protocol
Standard Dosage: 0.5 mg to 1 mg taken every other day, or 0.25 mg to 0.5 mg every day, adjusted based on individual response and blood work.
Cycle Integration: Initiated when estrogen-related symptoms appear or proactively alongside aromatizing compounds (e.g., testosterone) from week 1 or 2 of the cycle.
Post-Cycle Therapy (PCT): Generally avoided during standard PCT as it can overly suppress estrogen, which is necessary for hormonal recovery, though sometimes used in specific tapering protocols under strict supervision.
